Financial PerformanceKRMD delivered a strong quarter as it generated $10M in quarterly revenues for the first time and beat across the P&L, continuing to see material outperformance in its OUS markets.
Market ExpansionContinued upside potential from OUS expansion into current and new markets as KRMD works to increase its market share internationally, including pre-filled syringe tender opportunities.
Product DevelopmentKRMD is expanding its products with a next-gen pump and a new flow controller designed to open new global markets and accelerate revenue growth, reinforcing its competitive advantage in the SCIg market.
Revenue GuidanceKRMD raised its revenue guidance $1.0M at the midpoint, reflecting growth of now 18-20%, underpinned by 8-10% SCIg market growth, global share gains, NRE revenue from 3 new expected collaborations, and its flow controller line extension.